These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17181141)

  • 1. Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffold.
    Sun C; Robl JA; Wang TC; Huang Y; Kuhns JE; Lupisella JA; Beehler BC; Golla R; Sleph PG; Seethala R; Fura A; Krystek SR; An Y; Malley MF; Sack JS; Salvati ME; Grover GJ; Ostrowski J; Hamann LG
    J Med Chem; 2006 Dec; 49(26):7596-9. PubMed ID: 17181141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of diarylhydantoins as new selective androgen receptor modulators.
    Nique F; Hebbe S; Peixoto C; Annoot D; Lefrançois JM; Duval E; Michoux L; Triballeau N; Lemoullec JM; Mollat P; Thauvin M; Prangé T; Minet D; Clément-Lacroix P; Robin-Jagerschmidt C; Fleury D; Guédin D; Deprez P
    J Med Chem; 2012 Oct; 55(19):8225-35. PubMed ID: 22897611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a 4-(hydroxymethyl)diarylhydantoin as a selective androgen receptor modulator.
    Nique F; Hebbe S; Triballeau N; Peixoto C; Lefrançois JM; Jary H; Alvey L; Manioc M; Housseman C; Klaassen H; Van Beeck K; Guédin D; Namour F; Minet D; Van der Aar E; Feyen J; Fletcher S; Blanqué R; Robin-Jagerschmidt C; Deprez P
    J Med Chem; 2012 Oct; 55(19):8236-47. PubMed ID: 22957947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats.
    Ostrowski J; Kuhns JE; Lupisella JA; Manfredi MC; Beehler BC; Krystek SR; Bi Y; Sun C; Seethala R; Golla R; Sleph PG; Fura A; An Y; Kish KF; Sack JS; Mookhtiar KA; Grover GJ; Hamann LG
    Endocrinology; 2007 Jan; 148(1):4-12. PubMed ID: 17008401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potent and muscle selective androgen receptor modulators through scaffold modifications.
    Li JJ; Sutton JC; Nirschl A; Zou Y; Wang H; Sun C; Pi Z; Johnson R; Krystek SR; Seethala R; Golla R; Sleph PG; Beehler BC; Grover GJ; Fura A; Vyas VP; Li CY; Gougoutas JZ; Galella MA; Zahler R; Ostrowski J; Hamann LG
    J Med Chem; 2007 Jun; 50(13):3015-25. PubMed ID: 17552509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR of novel hydantoin derivatives as selective androgen receptor modulators.
    Zhang X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5763-6. PubMed ID: 16959487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-specific activation of the human skeletal alpha-actin by androgens.
    Hong MH; Sun H; Jin CH; Chapman M; Hu J; Chang W; Burnett K; Rosen J; Negro-Vilar A; Miner JN
    Endocrinology; 2008 Mar; 149(3):1103-12. PubMed ID: 18063690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulators.
    Manfredi MC; Bi Y; Nirschl AA; Sutton JC; Seethala R; Golla R; Beehler BC; Sleph PG; Grover GJ; Ostrowski J; Hamann LG
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4487-90. PubMed ID: 17574413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats.
    Gao W; Reiser PJ; Coss CC; Phelps MA; Kearbey JD; Miller DD; Dalton JT
    Endocrinology; 2005 Nov; 146(11):4887-97. PubMed ID: 16099859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators.
    Hamann LG; Manfredi MC; Sun C; Krystek SR; Huang Y; Bi Y; Augeri DJ; Wang T; Zou Y; Betebenner DA; Fura A; Seethala R; Golla R; Kuhns JE; Lupisella JA; Darienzo CJ; Custer LL; Price JL; Johnson JM; Biller SA; Zahler R; Ostrowski J
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1860-4. PubMed ID: 17292608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective androgen receptor modulator activity of a steroidal antiandrogen TSAA-291 and its cofactor recruitment profile.
    Hikichi Y; Yamaoka M; Kusaka M; Hara T
    Eur J Pharmacol; 2015 Oct; 765():322-31. PubMed ID: 26335395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer.
    Dalton JT; Taylor RP; Mohler ML; Steiner MS
    Curr Opin Support Palliat Care; 2013 Dec; 7(4):345-51. PubMed ID: 24189892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
    Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ
    J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of an imidazolopyrazole as novel selective androgen receptor modulator.
    Zhang X; Allan GF; Tannenbaum P; Sbriscia T; Linton O; Lai MT; Haynes-Johnson D; Bhattacharjee S; Lundeen SG; Sui Z
    J Steroid Biochem Mol Biol; 2013 Mar; 134():51-8. PubMed ID: 23098693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate.
    Miner JN; Chang W; Chapman MS; Finn PD; Hong MH; López FJ; Marschke KB; Rosen J; Schrader W; Turner R; van Oeveren A; Viveros H; Zhi L; Negro-Vilar A
    Endocrinology; 2007 Jan; 148(1):363-73. PubMed ID: 17023534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel selective androgen receptor modulator, NEP28, is efficacious in muscle and brain without serious side effects on prostate.
    Akita K; Harada K; Ichihara J; Takata N; Takahashi Y; Saito K
    Eur J Pharmacol; 2013 Nov; 720(1-3):107-14. PubMed ID: 24177288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I.
    Aikawa K; Miyawaki T; Hitaka T; Imai YN; Hara T; Miyazaki J; Yamaoka M; Kusaka M; Kanzaki N; Tasaka A; Shiraishi M; Yamamoto S
    Bioorg Med Chem; 2015 May; 23(10):2568-78. PubMed ID: 25862209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones.
    Higuchi RI; Arienti KL; López FJ; Mani NS; Mais DE; Caferro TR; Long YO; Jones TK; Edwards JP; Zhi L; Schrader WT; Negro-Vilar A; Marschke KB
    J Med Chem; 2007 May; 50(10):2486-96. PubMed ID: 17439112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulators.
    Piatnitski Chekler EL; Unwalla R; Khan TA; Tangirala RS; Johnson M; St Andre M; Anderson JT; Kenney T; Chiparri S; McNally C; Kilbourne E; Thompson C; Nagpal S; Weber G; Schelling S; Owens J; Morris CA; Powell D; Verhoest PR; Gilbert AM
    J Med Chem; 2014 Mar; 57(6):2462-71. PubMed ID: 24527807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of potent, substituted carbazoles as selective androgen receptor modulators (SARMs).
    Miller CP; Bhaket P; Muthukaman N; Lyttle CR; Shomali M; Gallacher K; Slocum C; Hattersley G
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7516-20. PubMed ID: 21036041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.